Go Pro
NASDAQ:UTRS

Minerva Surgical (UTRS) Stock Price, News & Analysis

Minerva Surgical logo

About Minerva Surgical Stock (NASDAQ:UTRS)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
656 shs
Market Capitalization
$1 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Minerva Surgical, Inc. is a medical technology company that develops and commercializes devices for the treatment of benign gynecologic conditions. The company’s flagship product, the Minerva System, is designed to perform next‐generation endometrial ablation—a minimally invasive procedure used to treat heavy menstrual bleeding. By combining real‐time visualization, precise treatment control and an integrated fluid management system, the Minerva System aims to deliver a consistent, single‐procedure solution for women seeking alternatives to traditional surgical interventions.

The Minerva System features a proprietary treatment device, single‐use accessories and an intuitive console interface. Its core technology allows physicians to visualize the uterine cavity during the procedure, automate the energy delivery process and maintain continuous fluid balance to enhance patient safety. This platform is intended for use in outpatient and ambulatory care settings, potentially reducing treatment times and improving patient recovery experiences compared with more invasive surgical approaches.

Headquartered in Redwood City, California, Minerva Surgical secured U.S. Food and Drug Administration clearance for its system in 2015 and commenced commercial launch shortly thereafter. Since that time, the company has focused on expanding its sales and training initiatives across the United States, partnering with gynecologists, ambulatory surgery centers and hospital systems to drive adoption. Minerva Surgical also pursues strategic collaborations to explore future applications of its thermal ablation technology.

Founded by Daniel P. Hale, who serves as chief executive officer, Minerva Surgical is led by a management team with combined expertise in medical device development, commercialization and women’s health. The board and executive leadership continue to guide the company’s efforts to broaden access to minimally invasive gynecologic treatments and to develop next‐generation solutions for physicians and patients alike.

AI Generated. May Contain Errors.

Receive UTRS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Minerva Surgical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

UTRS Stock News Headlines

Minerva Surgical Inc.
Why Is Minerva Surgical (UTRS) Stock Down 50% Today?
The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Chaikin Money Flow indicator has a new top retirement pick. The company holds three fast-growing businesses -- including an autonomous vehicle unit and a streaming service with 10x Netflix's reach -- any of which could be spun off in the next 12 to 24 months. It also pays a dividend, a rarity among high-growth AI names. Chaikin lays out the full case in a new free presentation, no email or credit card required.tc pixel
Minerva Surgical Inc UTRS
Minerva Surgical Reports Third Quarter 2023 Financial Results
See More Headlines

UTRS Stock Analysis - Frequently Asked Questions

Minerva Surgical, Inc. (NASDAQ:UTRS) released its quarterly earnings results on Wednesday, December, 1st. The company reported ($23.00) EPS for the quarter, missing analysts' consensus estimates of ($8.80) by $14.20. The firm earned $12.51 million during the quarter, compared to the consensus estimate of $12.23 million.

Minerva Surgical's stock reverse split before market open on Monday, October 2nd 2023.The 1-20 reverse split was announced on Monday, October 2nd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, October 2nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Minerva Surgical (UTRS) raised $100 million in an initial public offering on Friday, October 22nd 2021. The company issued 6,250,000 shares at a price of $15.00-$17.00 per share.

Shares of UTRS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Minerva Surgical investors own include Sangamo Therapeutics (SGMO), NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Meta Platforms (META), Adobe (ADBE) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
12/01/2021
Today
8/30/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:UTRS
CIK
1452965
Fax
N/A
Employees
160
Year Founded
2008

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$51.69 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
8,880,000
Free Float
8,124,000
Market Cap
$1 thousand
Optionable
Not Optionable
Beta
2.41

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:UTRS) was last updated on 8/30/2026 by MarketBeat.com Staff.
From Our Partners